Artificial Kidney Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 12.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Artificial Kidney Market Analysis
The artificial kidney market is expected to register a CAGR of 12.2% over the forecast period.
The artificial kidney market was significantly impacted during the COVID-19 pandemic due to a decline in kidney transplant activities across the world. According to the study published in Transplantation in June 2022, during COVID-19, there was a 16% global decrease in transplant activity, with kidney transplants being the most affected. Thus, a decline in kidney transplants may positively influence the artificial kidney market. Moreover, the initial phase of the pandemic hampered the supply chain of medical devices, including artificial kidneys. However, the market has huge potential to grow over the projected period due to the scarcity of kidney donors across the world.
The studied market is expected to grow owing to the prevalence of chronic kidney diseases, the scarcity of donors, and technological advances in artificial kidneys.
The growing burden of chronic diseases such as chronic kidney diseases, end-stage renal diseases, and kidney failure may drive the demand for artificial kidneys, as artificial kidneys are designed to work like the natural kidney, filtering the blood and maintaining the body's fluid balance. For instance, as per the article published in the journal Kidney International Supplements in April 2022, chronic kidney disease, a progressive condition, has affected over 10% of the general population worldwide to date, accounting for more than 800 million individuals. The large volume of the population affected by kidney diseases in the world is likely to contribute to the growth of the artificial kidney market over the forecast period.
The scarcity of kidney donors is expected to increase the demand for artificial kidneys for effective health management. For instance, according to the Kidney Foundation Funds Data published in 2022, there are more than 90,000 Americans on the kidney transplant waiting list, but just 26,309, or nearly one in every four, will receive a kidney transplant in 2022. This indicates a huge scarcity of donors for kidney transplants, and thus, it is expected to boost the artificial kidney market over the forecast period.
Another factor is the introduction of technologically advanced products like low-maintenance dialysis equipment and artificial kidneys. In March 2021, Baxter International Inc. announced the United States FDA clearance of its next-generation Artificial Kidney 98 dialysis machine, designed to be a portable and easy-to-use system to administer hemodialysis (HD) treatments. This indicated that companies are taking initiatives to establish a strong footprint and launch technologically advanced products in the market. The product launches also propel the growth of the market. For instance, in December 2021, FMS announced the release of the FX CorAL, a new hemodialysis dialyzer in the company's FX class of dialyzers that uses polysulfone (a unique plastic with superior filtering and hemocompatibility features).
Thus, all of the aforementioned variables, such as the rising incidence of chronic renal illnesses, the paucity of kidney transplant donors, and market leaders' strategic actions, are projected to drive market growth. However, the high cost associated with artificial kidneys may restrain market growth.
Artificial Kidney Market Trends
Wearable Artificial Kidney Segment is Expected to Hold a Significant Share in Market Over the Forecast Period
Wearable artificial kidneys are a sort of portable medical technology that allows patients to benefit from dialysis at home while going about their daily activities. This gadget improves the lives of patients with end-stage renal disease by eliminating hospital stays and enhancing physiological aspects by lowering hypertension. It reduces sodium retention as well as the risk of stroke and vascular disease, and it is less expensive than alternative medications for renal failure patients. The segment is driven by the rising prevalence of kidney diseases and strategic initiatives by market players, such as regulatory approval and product launches.
Wearable/portable kidneys improve dialysis by allowing for home dialysis and improving frequency and autonomy, which leads to an increase in the demand for wearable kidneys over the implantable kidney. Home dialysis has advantages over in-centre hemodialysis and has the potential to save the healthcare system money. There are several portable home hemodialysis systems available, including the NxStage System One (NxStage Medical Inc.), the 2008K home (Fresenius Medical Care), and the SC+ hemodialysis system (Quanta).
The regulatory authority's clearance of the wearable artificial kidney may expand market introduction and end-user access, supporting segment growth. For instance, in May 2021, the United States Patent and Trademark Office granted a patent to Victor Gura, MD, FASN, for a wearable artificial kidney, and the nephrologist said he would begin clinical trials for the device in the next few years. Additionally, the growing focus of market players on developing wearable artificial kidneys, which are expected to launch in the market, is expected to boost the market growth. For instance, in February 2023, NextKidney, a medical equipment firm that created the first portable hemodialysis machine, raised GBP 11.9 million (USD 14.82 million) in a Series B round of funding. NextKidney will use the funds for clinical trials and market clearance of the company's portable artificial kidney device.
Thus, all aforementioned factors, such as the growing burden of kidney diseases and regulatory approval and funding activities, are expected to boost the segment's growth over the forecast period.
North America is Expected to Hold a Significant Market Share Over the Forecast Period
North America is expected to witness a significant market share in the artificial kidney market over the forecast period. The major factors driving the market growth are the rising prevalence of chronic kidney diseases, the presence of well-established healthcare infrastructure along with high health spending, and technologically advanced products.
The growing burden of kidney diseases, which lead to kidney damage or failure, is likely to increase the demand for artificial kidneys. For instance, according to the National Institutes of Health data updated in September 2021, chronic kidney disease (CKD) affects nearly one-seventh of all adults in the United States (i.e., 37 million people). The risk of CKD is much higher for Americans with diabetes or high blood pressure, the two most frequent causes of kidney disease. Kidney disease affects nearly one-third of diabetics and one-fifth of those with high blood pressure. Heart disease and a family history of renal failure are two more risk factors for kidney disease. Patients with end-stage renal disease (ESRD) usually have a small bladder capacity and increased bladder sensation.
There has been a dramatic increase in focus on the development of the artificial kidney. For instance, in August 2022, the Kidney Innovation Accelerator will give USD 10.5 million to the American Society of Nephrology and the United States Department of Health and Human Services for a new prize competition. Similarly, in September 2021, the U.S. Department of Health and Human Services and the American Society of Nephrology announced the winners of Phase 1 of the KidneyX Artificial Kidney Prize based on their potential to advance the functionality, effectiveness, and reliability of the artificial kidney.
Thus, all aforementioned factors, such as the growing burden of chronic kidney diseases and the growing focus on the development of artificial kidneys, are expected to boost the market over the forecast period.
Artificial Kidney Industry Overview
The artificial kidney market is moderately competitive due to the presence of many major market players. Market players adopt organic strategies and product launches, which are prioritized by corporations with inorganic growth strategies, like acquisitions, partnerships, and collaborations. Some of the key market players are B. Braun Melsungen AG, Nipro Corporation, Fresenius SE & Co. KGaA, Baxter International Inc., Medtronic PLC, B. Braun SE, Asahi Kasei Medical Co. Ltd
Artificial Kidney Market Leaders
B. Braun Melsungen AG
Asahi Kasei Medical Co. Ltd.,
NIPRO Medical Corporation
Nikkiso Co., Ltd
Fresenius Medical Care AG & Co. KGaA
*Disclaimer: Major Players sorted in no particular order
Artificial Kidney Market News
- April 2023: Medtronic plc and DaVita In created a new company called Mozarc Medical, which is dedicated to changing renal health and developing patient-centred technological solutions.
- August 2022: The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) reported a new prize competition from the Kidney Innovation Accelerator (KidneyX) that seeks to further the development of a fully functional bioartificial kidney.
Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Chronic Kidney Diseases
4.2.2 Scarcity of Donor Organs
4.2.3 Technological Advancements in the Artificial Kidney
4.3 Market Restraints
4.3.1 Expensive Procedures and Products
4.3.2 Risks Associated With Artificial Kidney
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Wearable Artificial Kidney
5.1.2 Implantable Artificial Kidney
5.2 By End User
5.2.1 Hospitals
5.2.2 Specialty Clinics
5.2.3 Ambulatory Surgical Centers
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Asahi Kasei Medical Co. Ltd.,
6.1.3 DaVita Inc
6.1.4 NIPRO Medical Corporation
6.1.5 Nikkiso Co., Ltd
6.1.6 Fresenius Medical Care AG & Co. KGaA
6.1.7 Baxter
6.1.8 Medtronic
6.1.9 KAWASUMI LABORATORIES
6.1.10 Nanodialysis
6.1.11 AWAK Technologies
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Artificial Kidney Industry Segmentation
As per the scope of the report, the artificial kidney is a device known as a haemodialyzer that is used to filter the blood of a person suffering from kidney disease. It. It helps to minimize chronic renal disease and improve patients' quality of life. An artificial kidney is made up of silicon nano filters that remove water, salts, toxins, and other tiny molecules. Artificial Kidney Market is segmented by Device Type (Wearable Artificial Kidney and Implantable Artificial Kidney), End-User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above-mentioned segments.
| By Device Type | |
| Wearable Artificial Kidney | |
| Implantable Artificial Kidney |
| By End User | |
| Hospitals | |
| Specialty Clinics | |
| Ambulatory Surgical Centers |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Frequently Asked Questions
What is the current Artificial Kidney Market size?
The Artificial Kidney Market is projected to register a CAGR of 12.20% during the forecast period (2024-2029)
Who are the key players in Artificial Kidney Market?
B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., , NIPRO Medical Corporation, Nikkiso Co., Ltd and Fresenius Medical Care AG & Co. KGaA are the major companies operating in the Artificial Kidney Market.
Which is the fastest growing region in Artificial Kidney Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Artificial Kidney Market?
In 2024, the North America accounts for the largest market share in Artificial Kidney Market.
What years does this Artificial Kidney Market cover?
The report covers the Artificial Kidney Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Artificial Kidney Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Artificial Kidney Industry Report
Statistics for the 2024 Artificial Kidney market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Artificial Kidney analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
